FDA Updates
Published: 11/28/2023
Sources:
- Food and Drug Administration
Relevant To:
- All Healthcare Organizations
The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities:
- Antiseizure Medicines Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam): Drug Safety Communication - FDA Warns of Rare but Serious Drug Reaction
- Two Lots of Sandimmune Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL by Novartis: Recall - Due to Crystallization
- Unomedical A/S Recalls VariSoft Infusion Sets Due to Damage to the Connector Piece…